— Know what they know.
Not Investment Advice
Also trades as: 0HKF.L (LSE) · $vol 0M

AXSM NASDAQ

Axsome Therapeutics, Inc.
1W: -8.1% 1M: -14.6% 3M: -26.1% YTD: +0.3% 1Y: +51.2% 3Y: +148.0% 5Y: +436.7%
$179.25
-2.82 (-1.55%)
 
Weekly Expected Move ±5.7%
$159 $169 $179 $189 $200
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $9.2B mcap · 44M float · 1.85% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 859.1%
Cost Advantage
59
Intangibles
55
Switching Cost
48
Network Effect
82
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AXSM shows a Weak competitive edge (53.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 859.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$247
Low
$274
Avg Target
$316
High
Based on 9 analysts since Aug 10, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 26Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$279.64
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-29 Deutsche Bank — $280 $267 -13 +41.5% $188.66
2026-09-25 Morgan Stanley — $251 $247 -4 +24.4% $198.57
2026-09-23 Truist Financial Srikripa Devarakonda $200 $285 +85 +40.3% $203.10
2026-08-12 Mizuho Securities Graig Suvannavejh $230 $316 +86 +46.5% $215.77
2026-08-11 RBC Capital Leonid Timashev $304 $297 -7 +35.6% $219.00
2026-08-11 Morgan Stanley — $242 $251 +9 +13.5% $221.21
2026-08-11 Needham Ami Fadia $267 $268 +1 +21.3% $220.89
2026-08-11 Guggenheim — $260 $275 +15 +24.5% $220.89
2026-08-11 Wells Fargo — $202 $256 +54 +15.9% $220.89
2026-07-20 BMO Capital Malcolm Hoffman Initiated $310 — +39.9% $221.64
2026-07-07 RBC Capital Leonid Timashev $302 $304 +2 +25.3% $242.60
2026-06-11 Jefferies Andrew Tsai $275 $380 +105 +54.3% $246.34
2026-05-05 Deutsche Bank David Hoang $281 $280 -1 +21.7% $230.10
2026-05-05 Morgan Stanley — $217 $242 +25 +5.2% $230.11
2026-05-05 Needham — $225 $267 +42 +15.8% $230.63
2026-05-05 RBC Capital Leonid Timashev $222 $302 +80 +30.7% $231.00
2026-05-05 Robert W. Baird Brian Skorney $209 $246 +37 +10.0% $223.70
2026-05-05 H.C. Wainwright — $270 $290 +20 +29.6% $223.70
2026-05-04 Oppenheimer — $250 $280 +30 +25.4% $223.34
2026-05-04 Guggenheim Yatin Suneja $220 $260 +40 +14.4% $227.31
2026-05-04 Piper Sandler — $223 $258 +35 +13.5% $227.26
2026-05-04 Cantor Fitzgerald — Initiated $272 — +19.6% $227.39
2026-05-04 Jefferies Andrew Tsai $215 $275 +60 +20.7% $227.92
2026-05-04 Deutsche Bank David Hoang Initiated $281 — +23.6% $227.35
2026-05-04 H.C. Wainwright Raghuram Selvaraju $260 $270 +10 +30.7% $206.53
2026-05-01 Oppenheimer — $220 $250 +30 +24.4% $201.03
2026-04-30 Morgan Stanley — $207 $217 +10 +4.5% $207.75
2026-04-10 UBS — $251 $259 +8 +44.5% $179.25
2026-02-24 RBC Capital — $219 $222 +3 +31.9% $168.35
2026-02-24 UBS — $248 $251 +3 +46.9% $170.81
2026-02-24 Morgan Stanley — $204 $207 +3 +18.4% $174.76
2026-02-24 Guggenheim — $205 $220 +15 +25.9% $174.76
2026-02-24 Wells Fargo — $193 $202 +9 +15.6% $174.76
2026-02-23 Wolfe Research Rudy Li Initiated $230 — +31.6% $174.76
2026-02-23 Truist Financial Joon Lee $190 $200 +10 +15.2% $173.55
2026-02-23 Jefferies — Initiated $215 — +23.6% $173.90
2026-02-19 Mizuho Securities — $217 $230 +13 +24.5% $184.74
2026-01-21 RBC Capital Leonid Timashev $198 $219 +21 +18.7% $184.50
2026-01-20 H.C. Wainwright — $200 $260 +60 +46.7% $177.27
2026-01-16 Piper Sandler — $115 $223 +108 +28.1% $174.14
2026-01-13 Robert W. Baird — $162 $209 +47 +18.8% $175.99
2026-01-13 Wells Fargo — $157 $193 +36 +9.2% $176.82
2026-01-08 Morgan Stanley — $196 $204 +8 +19.5% $170.69
2026-01-06 UBS — Initiated $248 — +41.6% $175.15
2026-01-05 Needham Ami Fadia Initiated $225 — +25.9% $178.69
2026-01-05 H.C. Wainwright Raghuram Selvaraju $185 $200 +15 +11.9% $178.69
2026-01-02 Guggenheim Yatin Suneja $135 $205 +70 +14.4% $179.14
2025-12-31 Mizuho Securities Graig Suvannavejh $216 $217 +1 +18.7% $182.86
2025-12-31 Oppenheimer Jay Olson Initiated $220 — +20.5% $182.64
2025-11-04 H.C. Wainwright — $180 $185 +5 +38.0% $134.11

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AXSM receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-06 D+ C-
2026-05-04 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 47 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
23
Growth
86
Value
23
Momentum
78
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AXSM scores highest in Safety (100/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
9.06
Safe Zone
Piotroski F-Score
5/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-2.88
Unlikely Manipulator
Ohlson O-Score
-3.58
Bankruptcy prob: 2.7%
Low Risk
Credit Rating
BBB-
Score: 52.5/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.37x
Accruals: -17.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AXSM scores 9.06, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AXSM scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AXSM's score of -2.88 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AXSM's implied 2.7% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AXSM receives an estimated rating of BBB- (score: 52.5/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-47.80x
PEG
-1.68x
P/S
11.88x
P/B
110.82x
P/FCF
-176.58x
P/OCF
—
EV/EBITDA
-69.55x
EV/Revenue
16.10x
EV/EBIT
-67.21x
EV/FCF
-175.17x
Earnings Yield
-1.52%
FCF Yield
-0.57%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AXSM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.003
NI / EBT
×
Interest Burden
1.027
EBT / EBIT
×
EBIT Margin
-0.240
EBIT / Rev
×
Asset Turnover
1.108
Rev / Assets
×
Equity Multiplier
8.960
Assets / Equity
=
ROE
-245.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AXSM's ROE of -245.1% is driven by financial leverage (equity multiplier: 8.96x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$179.25
Median 1Y
$182.63
5th Pctile
$55.52
95th Pctile
$595.33
Ann. Volatility
72.9%
Analyst Target
$279.64
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Herriot Tabuteau, M.D.
Chief Executive Officer, President and Chairman of the Board
$835,000 $5,533,554 $10,283,492
Mark Jacobson, M.A.
Chief Operating Officer
$575,000 $2,082,943 $4,208,131
Nick Pizzie, C.P.A.,
M.B.A. Chief Financial Officer
$530,000 $1,822,596 $3,730,519
Hunter Murdock, Esq.
General Counsel
$530,000 $1,497,075 $3,224,304
Ari Maizel, M.B.A.
Chief Commercial Officer
$530,000 $1,497,075 $3,188,657

CEO Pay Ratio

17:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,283,492
Avg Employee Cost (SGA/emp): $616,864
Employees: 925

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
925
+35.4% YoY
Revenue / Employee
$690,266
Rev: $638,496,000
Profit / Employee
$-198,026
NI: $-183,174,000
SGA / Employee
$616,864
Avg labor cost proxy
R&D / Employee
$198,139
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -1.4% -2.0% -2.5% -3.5% -1.6% -3.0% -2.5% -1.3% -94.6% -1.6% -2.3% -1.6% -1.7% -2.3% -2.8% -2.8% -2.8% -2.5% -3.5% -2.5% -2.45%
ROA -78.4% -95.2% -1.1% -92.6% -70.2% -89.3% -66.4% -46.6% -43.0% -52.0% -63.4% -53.2% -53.5% -49.7% -48.7% -41.6% -37.3% -29.1% -28.7% -27.4% -27.35%
ROIC 4.3% 4.7% 5.4% -3.2% -5.0% -41.8% -9.0% -5.2% -4.0% 20.7% -114.3% 11.5% 5.7% 3.4% 5.9% 14.3% 5.1% -20.1% 4.5% 8.6% 8.59%
ROCE -1.3% -1.9% -2.1% -1.0% -54.7% -76.5% -51.3% -35.0% -39.8% -51.6% -72.9% -84.5% -83.8% -82.9% -76.6% -79.6% -71.4% -56.2% -66.1% -61.8% -61.82%
Gross Margin — — — 88.9% 88.6% 90.6% 92.0% 90.2% 88.7% 89.7% 91.6% 90.8% 91.9% 91.1% 91.9% 91.0% 93.0% 93.7% 92.3% 93.8% 93.79%
Operating Margin — — — -4.4% -2.5% -2.5% -6.7% -1.4% -1.1% -1.4% -89.7% -89.5% -59.8% -61.1% -46.9% -24.5% -27.0% -15.0% -33.1% -22.7% -22.73%
Net Margin — — — -4.7% -2.7% -2.5% -11.9% -1.4% -1.1% -1.4% -91.1% -91.0% -61.7% -63.1% -48.9% -32.0% -27.6% -14.6% -33.8% -23.5% -23.50%
EBITDA Margin — — — -4.4% -2.4% -2.4% -5.0% -1.3% -1.0% -1.3% -87.3% -87.3% -57.8% -59.4% -45.2% -28.4% -26.0% -12.6% -31.9% -22.7% -22.73%
FCF Margin — — — -13.9% -4.6% -2.3% -62.4% -61.3% -64.0% -53.8% -77.0% -57.6% -39.2% -33.3% -27.4% -24.3% -18.0% -14.6% -10.0% -9.2% -9.19%
OCF Margin — — — -13.8% -4.6% -2.3% -62.0% -61.1% -63.7% -53.6% -76.8% -57.5% -39.2% -33.3% -27.4% -24.4% -18.0% -14.6% -10.0% -9.2% -9.18%
ROE 3Y Avg snapshot only -2.89%
ROE 5Y Avg snapshot only -3.84%
ROA 3Y Avg snapshot only -40.01%
ROIC Economic snapshot only -51.90%
Cash ROA snapshot only -9.36%
NOPAT Margin snapshot only -19.18%
Pretax Margin snapshot only -24.61%
R&D / Revenue snapshot only 24.19%
SGA / Revenue snapshot only 91.77%
SBC / Revenue snapshot only 12.42%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -9.89 -10.94 -11.27 -9.98 -11.64 -17.91 -16.91 -17.01 -16.32 -15.75 -12.76 -12.41 -13.91 -14.30 -20.48 -20.90 -26.47 -50.48 -45.96 -65.78 -47.800
P/S Ratio — — — 169.71 72.50 66.97 18.56 17.20 14.74 13.92 15.07 13.14 12.78 10.65 13.19 10.43 10.82 14.48 12.22 16.23 11.878
P/B Ratio 29.07 91.28 107.92 98.48 11.83 30.59 24.01 11.26 12.22 19.72 26.26 37.23 46.57 72.04 107.13 70.63 82.40 104.73 158.53 151.32 110.817
P/FCF -12.39 -13.18 -13.93 -12.25 -15.77 -28.59 -29.75 -28.03 -23.02 -25.86 -19.56 -22.79 -32.63 -31.98 -48.20 -42.83 -60.13 -98.87 -121.92 -176.58 -176.582
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -9.90 -11.25 -11.58 -10.67 -11.53 -18.50 -18.19 -17.36 -16.47 -15.89 -12.76 -12.42 -14.04 -14.62 -21.41 -22.21 -28.11 -55.05 -49.61 -69.55 -69.553
EV/Revenue — — — 172.06 67.31 64.85 17.88 15.81 13.70 13.18 14.50 12.71 12.38 10.33 12.98 10.25 10.63 14.36 12.10 16.10 16.103
EV/EBIT -9.83 -11.15 -11.48 -10.58 -11.33 -18.05 -17.48 -16.61 -15.83 -15.39 -12.43 -12.12 -13.69 -14.20 -20.76 -21.41 -27.06 -52.42 -47.28 -67.21 -67.207
EV/FCF -11.74 -12.84 -13.63 -12.42 -14.64 -27.68 -28.65 -25.78 -21.41 -24.49 -18.83 -22.06 -31.61 -31.02 -47.44 -42.12 -59.07 -97.99 -120.71 -175.17 -175.172
Earnings Yield -10.1% -9.1% -8.9% -10.0% -8.6% -5.6% -5.9% -5.9% -6.1% -6.4% -7.8% -8.1% -7.2% -7.0% -4.9% -4.8% -3.8% -2.0% -2.2% -1.5% -1.52%
FCF Yield -8.1% -7.6% -7.2% -8.2% -6.3% -3.5% -3.4% -3.6% -4.3% -3.9% -5.1% -4.4% -3.1% -3.1% -2.1% -2.3% -1.7% -1.0% -0.8% -0.6% -0.57%
Price/Tangible Book snapshot only 371.809
EV/Gross Profit snapshot only 17.271
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.66 3.75 3.54 2.44 4.19 2.54 3.02 4.52 4.46 3.63 3.20 2.48 2.44 2.11 2.03 1.57 1.57 1.55 1.39 1.43 1.426
Quick Ratio 4.66 3.75 3.54 2.20 4.15 2.50 2.95 4.44 4.38 3.52 3.09 2.40 2.37 2.04 1.96 1.51 1.50 1.48 1.32 1.34 1.344
Debt/Equity 1.17 3.18 3.42 6.20 0.60 0.86 1.32 0.66 0.69 0.98 1.32 1.86 2.07 3.38 3.97 2.97 2.96 2.73 4.03 2.63 2.631
Net Debt/Equity -1.51 -2.35 -2.34 1.37 -0.85 -0.97 -0.88 -0.91 -0.86 -1.05 -0.99 -1.20 -1.45 -2.15 -1.69 -1.17 -1.45 -0.92 -1.56 -1.21 -1.208
Debt/Assets 0.43 0.57 0.57 0.52 0.28 0.29 0.38 0.30 0.31 0.32 0.35 0.35 0.34 0.34 0.35 0.34 0.33 0.35 0.31 0.29 0.288
Debt/EBITDA -0.42 -0.40 -0.38 -0.66 -0.63 -0.54 -1.04 -1.11 -1.00 -0.83 -0.66 -0.64 -0.64 -0.71 -0.81 -0.95 -1.03 -1.45 -1.27 -1.22 -1.219
Net Debt/EBITDA 0.54 0.30 0.26 -0.15 0.89 0.61 0.70 1.52 1.24 0.89 0.50 0.42 0.45 0.45 0.34 0.38 0.50 0.49 0.49 0.56 0.560
Interest Coverage -20.65 -21.89 -24.03 -22.27 -20.67 -24.52 -17.92 -19.91 -27.35 -35.93 -55.54 -79.61 -60.51 -42.71 -34.13 -28.04 -29.04 -26.67 -34.13 -37.09 -37.088
Equity Multiplier 2.73 5.62 6.03 11.88 2.15 3.03 3.48 2.19 2.23 3.08 3.79 5.33 6.04 9.97 11.21 8.76 9.08 7.81 13.07 9.14 9.141
Cash Ratio snapshot only 0.695
Debt Service Coverage snapshot only -35.837
Cash to Debt snapshot only 1.459
FCF to Debt snapshot only -0.326
Defensive Interval snapshot only 238.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.05 0.11 0.24 0.61 0.46 0.48 0.59 0.54 0.50 0.58 0.67 0.76 0.83 0.91 1.01 1.08 1.11 1.108
Inventory Turnover — — — 0.19 2.76 2.41 3.21 1.67 3.47 2.68 2.11 2.31 2.49 2.16 2.31 2.51 2.40 2.17 2.19 1.87 1.865
Receivables Turnover — — — 1.09 2.53 2.65 6.46 4.37 4.53 4.08 3.43 3.11 3.34 3.26 3.29 3.10 3.50 3.48 3.43 3.26 3.261
Payables Turnover 0.00 0.00 0.00 0.06 0.22 0.20 0.53 0.52 1.00 0.66 0.55 0.54 0.65 0.59 0.53 0.55 0.77 0.69 0.54 0.62 0.616
DSO — — — 335 144 137 57 84 81 89 106 118 109 112 111 118 104 105 106 112 111.9 days
DIO — — — 1917 132 152 114 218 105 136 173 158 147 169 158 146 152 168 167 196 195.7 days
DPO — — — 5763 1646 1817 692 696 365 555 659 673 565 617 692 662 474 529 670 593 592.7 days
Cash Conversion Cycle — — — -3512 -1370 -1528 -522 -394 -179 -330 -380 -398 -309 -336 -422 -398 -217 -256 -397 -285 -285.1 days
Fixed Asset Turnover snapshot only 38.768
Operating Cycle snapshot only 307.6 days
Cash Velocity snapshot only 2.428
Capital Intensity snapshot only 0.981
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — 19.7% 7.7% 4.4% 73.6% 59.7% 51.5% 42.5% 72.2% 69.8% 65.8% 65.5% 63.9% 56.9% 56.87%
Net Income -27.4% -26.7% -41.2% -31.9% -27.3% -43.5% -12.7% -23.0% -26.2% -27.8% -86.7% -67.3% -54.1% -20.1% 6.1% 20.0% 26.2% 36.2% 32.3% 22.4% 22.38%
EPS -26.2% -25.3% -37.9% -26.9% -15.0% -24.7% 0.7% -10.1% -11.7% -17.4% -71.5% -53.6% -50.8% -17.1% 8.9% 23.0% 29.0% 38.9% 35.4% 25.5% 25.48%
FCF -32.8% -37.9% -38.1% -37.3% -17.7% -8.3% 20.7% 8.4% -21.2% -24.3% -1.1% -50.1% 7.3% 11.8% 38.8% 28.3% 23.8% 27.2% 40.0% 40.8% 40.76%
EBITDA -22.5% -23.2% -40.5% -31.5% -26.0% -42.0% -6.1% -16.9% -24.1% -28.0% -1.0% -79.5% -60.6% -21.4% 8.2% 23.4% 28.9% 38.9% 34.1% 21.3% 21.32%
Op. Income -25.1% -25.8% -43.0% -33.4% -27.2% -44.2% -9.4% -21.1% -26.9% -28.9% -97.9% -75.9% -58.3% -21.0% 7.7% 25.1% 30.6% 39.7% 35.0% 17.6% 17.64%
OCF Growth snapshot only 40.93%
Asset Growth snapshot only 19.02%
Equity Growth snapshot only 14.00%
Debt Growth snapshot only 0.87%
Shares Change snapshot only 4.16%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — 2.8% 1.8% 1.3% 69.8% 62.0% 62.05%
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — 2.9% 1.8% 1.4% 70.7% 63.3% 63.35%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 93.4% 78.7% 26.4% 48.8% 96.8% 14.5% 25.3% 47.4% 43.4% 46.7% 48.4% 56.4% 68.9% 86.4% 88.9% 52.5% 25.5% 27.7% 22.4% 7.6% 7.58%
Assets 5Y 27.3% 18.1% 13.8% 35.8% 59.7% 56.3% 69.4% 94.9% 1.1% 1.1% 65.5% 58.5% 66.1% 20.8% 24.7% 27.4% 26.9% 30.0% 33.7% 39.7% 39.67%
Equity 3Y 2.9% 1.6% -5.4% -14.5% 1.8% -15.1% -10.5% 21.8% 25.8% 18.8% 14.4% 12.9% 29.6% 53.9% 53.5% 68.8% -22.3% -6.9% -21.3% -33.1% -33.15%
Book Value 3Y 2.4% 1.4% -10.0% -18.5% 1.7% -21.1% -15.2% 15.4% 16.4% 9.8% 5.7% 4.4% 19.4% 41.6% 41.6% 56.1% -26.9% -11.6% -25.4% -36.7% -36.72%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 1.00 1.00 0.41 0.41 0.41 0.41 0.44 0.48 0.53 0.68 0.70 0.73 0.76 0.83 0.85 0.87 0.88 0.91 0.93 0.928
Earnings Stability 0.88 0.89 0.90 0.92 0.95 0.95 0.97 0.99 0.99 0.98 0.86 0.90 0.93 0.99 0.86 0.81 0.75 0.53 0.46 0.38 0.382
Margin Stability — — — — — — — — — — — 0.99 0.99 0.99 0.99 0.99 0.98 0.99 0.99 0.99 0.986
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.89 0.89 0.84 0.87 0.89 0.83 0.95 0.91 0.90 0.89 0.50 0.50 0.50 0.92 0.98 0.92 0.90 0.86 0.87 0.91 0.910
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 1.32 -7.70 -8.77 -8.76 0.82 2.92 3.89 5.07 1.23 3.77 3.44 2.26 -2.46 -3.56 -3.49 -1.55 -1.07 1.07 0.19 0.89 0.889
Gross Margin Trend — — — — — — — — — — — 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.023
FCF Margin Trend — — — — — — — — — — — 6.66 2.23 1.11 0.42 0.35 0.34 0.29 0.42 0.32 0.318
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.80 0.83 0.81 0.81 0.74 0.62 0.57 0.60 0.70 0.61 0.65 0.54 0.43 0.45 0.43 0.49 0.44 0.51 0.38 0.37 0.372
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.002
FCF/Net Income snapshot only 0.373
CapEx/Revenue — — — 4.6% 0.8% 1.4% 0.4% 0.2% 0.3% 0.2% 0.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.02%
CapEx/Depreciation snapshot only 0.021
Accruals Ratio -0.16 -0.16 -0.21 -0.17 -0.18 -0.34 -0.29 -0.18 -0.13 -0.20 -0.22 -0.24 -0.31 -0.27 -0.28 -0.21 -0.21 -0.14 -0.18 -0.17 -0.172
Sloan Accruals snapshot only -0.007
Cash Flow Adequacy snapshot only -552.395
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.8% -0.6% -2.1% -4.3% -13.2% -7.4% -8.0% -13.0% -7.9% -6.9% -6.9% -1.4% -0.8% -1.2% -1.2% -1.8% -1.7% -1.2% -1.2% -0.9% -0.93%
Total Shareholder Return -0.8% -0.6% -2.1% -4.3% -13.2% -7.4% -8.0% -13.0% -7.9% -6.9% -6.9% -1.4% -0.8% -1.2% -1.2% -1.8% -1.7% -1.2% -1.2% -0.9% -0.93%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.01 1.01 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
Interest Burden (EBT/EBIT) 1.05 1.05 1.04 1.04 1.05 1.04 1.06 1.05 1.04 1.03 1.02 1.01 1.02 1.02 1.03 1.05 1.04 1.05 1.04 1.03 1.027
EBIT Margin — — — -16.27 -5.94 -3.59 -1.02 -0.95 -0.87 -0.86 -1.17 -1.05 -0.90 -0.73 -0.63 -0.48 -0.39 -0.27 -0.26 -0.24 -0.240
Asset Turnover 0.00 0.00 0.00 0.05 0.11 0.24 0.61 0.46 0.48 0.59 0.54 0.50 0.58 0.67 0.76 0.83 0.91 1.01 1.08 1.11 1.108
Equity Multiplier 1.80 2.12 2.30 3.74 2.28 3.35 3.78 2.69 2.20 3.06 3.65 3.04 3.21 4.66 5.79 6.75 7.39 8.66 12.16 8.96 8.960
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-3.33 $-3.45 $-3.67 $-3.84 $-3.83 $-4.31 $-3.65 $-4.22 $-4.28 $-5.05 $-6.25 $-6.49 $-6.46 $-5.92 $-5.69 $-4.99 $-4.59 $-3.62 $-3.68 $-3.72 $-3.72
Book Value/Share $1.13 $0.41 $0.38 $0.39 $3.77 $2.52 $2.57 $6.38 $5.72 $4.04 $3.04 $2.16 $1.93 $1.17 $1.09 $1.48 $1.47 $1.74 $1.07 $1.62 $1.62
Tangible Book/Share $1.13 $0.41 $0.38 $-1.52 $2.02 $0.91 $1.00 $4.81 $4.30 $2.65 $1.69 $0.86 $0.67 $-0.04 $-0.09 $0.35 $0.39 $0.71 $0.07 $0.66 $0.66
Revenue/Share $0.00 $0.00 $0.00 $0.23 $0.62 $1.15 $3.32 $4.18 $4.74 $5.72 $5.30 $6.13 $7.03 $7.95 $8.84 $10.01 $11.22 $12.61 $13.83 $15.08 $15.08
FCF/Share $-2.66 $-2.87 $-2.97 $-3.13 $-2.83 $-2.70 $-2.07 $-2.56 $-3.04 $-3.08 $-4.08 $-3.53 $-2.75 $-2.65 $-2.42 $-2.44 $-2.02 $-1.85 $-1.39 $-1.39 $-1.39
OCF/Share $-2.65 $-2.87 $-2.97 $-3.12 $-2.82 $-2.68 $-2.06 $-2.55 $-3.02 $-3.07 $-4.07 $-3.52 $-2.75 $-2.65 $-2.42 $-2.44 $-2.02 $-1.84 $-1.38 $-1.38 $-1.38
Cash/Share $3.04 $2.29 $2.21 $1.88 $5.46 $4.62 $5.66 $10.01 $8.84 $8.16 $6.99 $6.64 $6.80 $6.50 $6.16 $6.13 $6.50 $6.38 $5.96 $6.21 $6.21
EBITDA/Share $-3.15 $-3.27 $-3.50 $-3.64 $-3.59 $-4.04 $-3.27 $-3.81 $-3.95 $-4.74 $-6.02 $-6.27 $-6.20 $-5.62 $-5.36 $-4.62 $-4.25 $-3.29 $-3.37 $-3.49 $-3.49
Debt/Share $1.33 $1.32 $1.31 $2.41 $2.26 $2.18 $3.39 $4.23 $3.94 $3.94 $4.00 $4.03 $3.99 $3.98 $4.32 $4.40 $4.37 $4.77 $4.30 $4.26 $4.26
Net Debt/Share $-1.71 $-0.97 $-0.90 $0.53 $-3.19 $-2.44 $-2.27 $-5.78 $-4.90 $-4.22 $-3.00 $-2.60 $-2.81 $-2.52 $-1.83 $-1.73 $-2.13 $-1.61 $-1.66 $-1.95 $-1.95
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 9.062
Altman Z-Prime snapshot only 13.478
Piotroski F-Score 1 1 1 2 4 4 4 6 5 4 4 3 3 3 4 5 5 4 5 5 5
Beneish M-Score — — — — — — — 0.64 -0.64 -1.60 -2.01 -2.92 -3.33 -3.25 -3.15 -2.76 -2.85 -2.55 -2.74 -2.88 -2.876
Ohlson O-Score snapshot only -3.580
ROIC (Greenblatt) snapshot only -86.08%
Net-Net WC snapshot only $-0.42
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 49.89 32.18 33.62 20.54 55.39 62.17 54.67 62.02 62.17 59.58 50.82 42.72 41.33 32.35 49.23 44.08 52.34 53.91 51.55 52.53 52.531
Credit Grade snapshot only 10
Credit Trend snapshot only 8.452
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 50
Sector Credit Rank snapshot only 46

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms